Lilly's Approach To The Clinical Trial Paradox

When I sat down with Eli Lilly and Company's chief medical officer and coleader of the company's Development Center of Excellence, Timothy Garnett, it was shortly after the drugmaker's annual investment community meeting where bankers grilled the leadership team with questions.

http://ift.tt/1ej0BpT